Zhiwei Cao
-
- Computational Drug Discovery Methods 16
- Pharmacology top 2%
- Geriatrics and Gerontology top 5%
- Molecular Biology top 5%
- Bioinformatics and Genomic Networks 10
- vaccines and immunoinformatics approaches 9
- Machine Learning in Bioinformatics 8
- Metabolomics and Mass Spectrometry Studies 5
- Glycosylation and Glycoproteins Research 4
- Genomics and Phylogenetic Studies 4
-
- Monoclonal and Polyclonal Antibodies Research 7
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Zhiwei Cao
66 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 132
- Computational Theory and Mathematics 471
- Pharmacology 244
- Geriatrics and Gerontology 97
- Complementary and alternative medicine 181
- Molecular Biology 1.4k
Countries citing papers authored by Zhiwei Cao
This map shows the geographic impact of Zhiwei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Cao more than expected).
Fields of papers citing papers by Zhiwei Cao
This network shows the impact of papers produced by Zhiwei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Cao. The network helps show where Zhiwei Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhiwei Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 9 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 20 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 5 | |
| 9 | 2017 | 40 | |
| 10 | 2015 | 30 | |
| 11 | 2014 | 10 | |
| 12 | 2012 | 17 | |
| 13 | 2012 | 14 | |
| 14 | Does difference exist between epitope and non-epitope residues? Analysis of the physicochemical and structural properties on conformational epi-topes from B-cell protein antigens. | 2011 | 35 |
| 15 | 2011 | 4 | |
| 16 | 2010 | 41 | |
| 17 | 2007 | 162 | |
| 18 | 2007 | 69 | |
| 19 | 2006 | 164 | |
| 20 | 2006 | 22 |
About Zhiwei Cao
Zhiwei Cao is a scholar working on Computational Theory and Mathematics, Pharmacology and Molecular Biology, having authored 70 papers that have together received 2.1k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (16 papers), Bioinformatics and Genomic Networks (10 papers), vaccines and immunoinformatics approaches (9 papers), Machine Learning in Bioinformatics (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Genomics and Phylogenetic Studies (4 papers). The work is most often cited by research in Computational Theory and Mathematics (471 citations), Pharmacology (244 citations) and Geriatrics and Gerontology (97 citations). Zhiwei Cao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Kailin Tang, Hongyan Zhu, Y LI, Yu Chen, Lianyi Han, Ruixin Zhu, Lin Tao, Qi Liu, Yixue Li and Tianyi Qiu. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.